FDA Inspection 926547 — Brigham And Women's Hospital

Brigham And Women's Hospital — FEI 1270016

The FDA completed an inspection of Brigham And Women's Hospital on March 31, 2015 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 31, 2015
Fiscal Year
2015
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Boston, MA (United States)